Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-09 4:31 pm Unchanged | 2025-06-06 | 13D | Aytu BioPharma, Inc. AYTU | Nantahala Capital Management, LLC | 1,086,812 14.400% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:50 pm Purchase | 2025-03-31 | 13G | Fossil Group, Inc. FOSL | Nantahala Capital Management, LLC | 4,189,177 7.870% | 862,500 (+25.93%) | Filing History |
| 2025-05-15 4:49 pm Purchase | 2025-03-31 | 13G | Elutia Inc. ELUT | Nantahala Capital Management, LLC | 3,689,067 9.990% | 705,499 (+23.65%) | Filing History |
| 2025-05-15 4:47 pm Purchase | 2025-03-31 | 13G | Evolus, Inc. EOLS | Nantahala Capital Management, LLC | 3,751,343 5.900% | 926,494 (+32.80%) | Filing History |
| 2025-05-15 4:46 pm Sale | 2025-03-31 | 13G | eHealth, Inc. EHTH | Nantahala Capital Management, LLC | 1,311,441 4.380% | -600,380 (-31.40%) | Filing History |
| 2025-05-15 4:46 pm Purchase | 2025-03-31 | 13G | Grace Therapeutics, Inc. GRCE | Nantahala Capital Management, LLC | 1,391,773 9.990% | 1,391,773 (New Position) | Filing History |
| 2025-05-15 4:46 pm Purchase | 2025-03-31 | 13G | Edesa Biotech, Inc. EDSA | Nantahala Capital Management, LLC | 700,488 9.990% | 700,488 (New Position) | Filing History |
| 2025-05-15 4:45 pm Sale | 2025-03-31 | 13G | Gaia, Inc. GAIA | Nantahala Capital Management, LLC | 914,618 4.650% | -411 (-0.04%) | Filing History |
| 2025-05-15 4:41 pm Unchanged | 2025-03-31 | 13G | Senti Biosciences, Inc. SNTI | Nantahala Capital Management, LLC | 2,220,000 8.120% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:41 pm Purchase | 2025-03-31 | 13G | Altisource Portfolio Solutions S.A. ASPS | Nantahala Capital Management, LLC | 309,664 2.820% | 43,629 (+16.40%) | Filing History |
| 2025-05-15 4:40 pm Purchase | 2025-03-31 | 13G | Abeona Therapeutics Inc. ABEO | Nantahala Capital Management, LLC | 4,997,101 9.990% | 570,719 (+12.89%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | Verastem, Inc. VSTM | Nantahala Capital Management, LLC | 5,459,278 9.990% | 936,094 (+20.70%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | BiomX Inc. PHGE | Nantahala Capital Management, LLC | 2,494,197 9.990% | 700,056 (+39.02%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 1,224,339 9.990% | 136,424 (+12.54%) | Filing History |
| 2025-05-15 4:38 pm Unchanged | 2025-03-31 | 13G | Benitec Biopharma Inc. BNTC | Nantahala Capital Management, LLC | 1,038,371 4.390% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:37 pm Purchase | 2025-03-31 | 13G | Third Harmonic Bio, Inc. THRD | Nantahala Capital Management, LLC | 2,938,700 6.520% | 2,938,700 (New Position) | Filing History |
| 2025-05-15 4:36 pm Purchase | 2025-03-31 | 13G | Senti Biosciences, Inc. SNTI | Nantahala Capital Management, LLC | 2,220,000 8.120% | 1,710,717 (+335.91%) | Filing History |
| 2025-05-15 4:36 pm Purchase | 2025-03-31 | 13G | Avalo Therapeutics, Inc. AVTX | Nantahala Capital Management, LLC | 900,000 8.430% | 900,000 (New Position) | Filing History |
| 2025-05-15 4:33 pm Purchase | 2025-03-31 | 13G | Opus Genetics, Inc. IRD | Nantahala Capital Management, LLC | 4,697,656 9.990% | 4,697,656 (New Position) | Filing History |
| 2025-05-15 4:32 pm Purchase | 2025-03-31 | 13G | InspireMD, Inc. NSPR | Nantahala Capital Management, LLC | 3,037,935 9.990% | 328,817 (+12.14%) | Filing History |